ConductScience.org, home

Paper · 39133448

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.

McDonald HG and 19 others. Ann Surg Oncol, 2024. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Development of a Novel Protocol for Germline Testing in Pancreatic Cancer. Papers, record 39133448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39133448

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.
PubMed
Journal
Ann Surg Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.65, provisional
iCite
Revised in PubMed
2026-09-16
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McDonald HGHannah G
2Kennedy AAndrew
3Solomon ALAngelica L
4Williams CMChelsey M
5Reagan AMAnna M
6Cassim EEmily
7Harper MMegan
8Burke EErin
9Armstrong TTerra
10Gosky MMichael

1 to 10 of 20Source PubMed

See all 20 authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Germ-Line MutationMajor topic
Genetic TestingMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Humans
Female
Male
Middle Aged
Genetic Counseling
Aged
Follow-Up Studies
Biomarkers, Tumor
Prognosis
Genetic Predisposition to Disease
Prospective Studies
Adult
Clinical Protocols

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 CA160003NCI NIH HHSUnited StatesT32CA160003PubMedNIH RePORTER
NIH T32CA60003NIH HHSUnited StatesPubMedPubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119,806,144Epidemiology of pancreatic cancer: an overview.Nat Rev Gastroenterol Hepatol2009https://conductscience.org/library/papers/19806144PubMed
231,672,839Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.Gut2020https://conductscience.org/library/papers/31672839PubMed
332,755,482Metastatic Pancreatic Cancer: ASCO Guideline Update.J Clin Oncol2020https://conductscience.org/library/papers/32755482PubMed
432,416,142AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.Gastroenterology2020https://conductscience.org/library/papers/32416142PubMed
533,845,462Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2021https://conductscience.org/library/papers/33845462PubMed
623,774,698Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review.Pancreas2013https://conductscience.org/library/papers/23774698PubMed
715,059,921Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.Cancer Res2004https://conductscience.org/library/papers/15059921PubMed
829,069,866Germline mutations in pancreatic cancer and potential new therapeutic options.Oncotarget2017https://conductscience.org/library/papers/29069866PubMed
930,699,894Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.Int J Mol Sci2019https://conductscience.org/library/papers/30699894PubMed
1032,099,470Familial Pancreatic Cancer: Current Perspectives.Cancer Manag Res2020https://conductscience.org/library/papers/32099470PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41,990,298Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.JCO Precis Oncol2026https://conductscience.org/library/papers/41990298PubMed
41,611,968Results of a multigene panel testing approach targeting patients with suspected genetic predisposition to pancreatic ductal adenocarcinoma.Eur J Hum Genet2026https://conductscience.org/library/papers/41611968PubMed

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39133448

GET https://conductscience.org/api/papers/v1/39133448/references?page=2